News

Photo

Topsoe Wins Ammonia, Methanol Contracts

Danish technology company Haldor Topsoe has been chosen by Ascension Clean Energy (ACE) to provide its Syncor autothermal reforming technology for a world-scale ammonia plant to be built in Louisiana, USA.

Photo

Jobs to Go at Novartis US Headquarters

As part of plans, announced in dribbles, to carve 8,000 jobs out of its global workforce to save $1 billion, Swiss drugs giant Novartis is eliminating 285 staff positions across its headquarters sites in the US state of New Jersey.

Photo

Trinseo Closes German Styrene and PC Production

Trinseo has finally decided to stop producing styrene at its Böhlen site in Germany, saying the plant – producing about 300,000 t/y – is too small to be competitive on the global market with current high gas prices and new styrene capacity additions sealing the unit’s fate.

Photo

Brenntag Expands South American Facilities

Brenntag has opened a new facility in Zarate, Argentina, unifying its operations in Buenos Aires into a single site and expanding its capabilities to customers. The site comprises offices, warehouses, storage tanks, three tank truck unloading spaces, two drumming stations and a mixing and blending building.

Photo

BioNTech to Set up Oncology Base in Taiwan

Germany’s BioNTech said it plans to accelerate and broaden the clinical development of its cancer immunotherapy pipeline in the Asia-Pacific region by expanding its clinical footprint to East Asia, specifically Taiwan.

Photo

German Chemicals Stagger under Energy Burden

The global chemical industry has seen its share of challenges, but the sector has traditionally mustered its considerable resources to manage them with a minimum of casualties. Crisis here, recession there, when all blows over, it‘s “business as usual.”

Photo

GSK and Wave Life Sciences Partner on Genetics

British pharma GSK has entered into a four-year collaboration with US clinical-stage genetic medicines company Wave Life Sciences to advance oligonucleotide therapeutics, including Wave’s preclinical RNA-editing program targeting alpha-1 antitrypsin deficiency (AATD), an inherited disorder that can cause lung and liver disease.

Photo

Synthomer Sells Laminates, Films and Fabrics to Surteco

UK chemicals company Synthomer is selling its laminates, films and coated fabrics businesses to Germany’s Surteco Group for $255 million. The sale is part of Synthomer’s realignment of its portfolio to focus on specialty chemicals.

Photo

Chinese Distributor Inks Paxlovid Deal with Pfizer

As Covid cases continue to explode across the country, China Meheco Group Co, an internationally active manufacturer and distributor of pharmaceuticals chemicals and biologicals as well as Chinese traditional medical products, has struck a deal with Pfizer to distribute the US pharma giant’s oral antiviral Paxlovid in the People’s Republic.

Photo

Clariant Expands Care Chemicals in China

Specialty chemicals producer Clariant said it will invest 80 million Swiss francs to increase output of existing products in the portfolio it manufactures at Daya Bay, Huizhou, China, as well as introducing new products there by the end of 2024.

Photo

Takeda Takes Nimbus Lakshmi for $4 Billion

Japanese pharma Takeda is acquiring Nimbus Lakshmi, a wholly-owned subsidiary of US clinical-stage drug discovery company Nimbus Therapeutics, and its tyrosine kinase 2 (TYK2) inhibitor NDI-034858, which is undergoing trials for treating multiple autoimmune diseases, including psoriasis.

Photo

Pfizer to Invest $750 million in Michigan

Pfizer is planning to invest $750 million in its Kalamazoo County, Michigan, production site – one of its biggest – to increase output of injectables and vaccines, including the investigational mRNA flu shot currently in Phase 3 clinical trials.

Photo

Amgen Boosts Rare Diseases with Horizon Buy

Amgen has agreed to buy Horizon Therapeutics for $28.3 billion including debt, boosting its portfolio of drugs for rare autoimmune and inflammatory diseases and beating rivals Sanofi and Johnson & Johnson, as well as a fourth unnamed company.

Photo

French Farmer Wins €11,000 in Bayer Herbicide Lawsuit

A French farmer who said he suffered neurological problems including memory loss, fainting and headaches after inhaling fumes from Bayer’s Lasso-branded herbicide in an agricultural accident, has won compensation of €11,135, ending more than 15 years of litigation.

Photo

Novozymes and Chr. Hansen to Merge

Danish companies Novozymes and Chr. Hansen have agreed to merge, in a move they termed a perfect match that will create a global leader in biosolutions.

Photo

BP Studies Hydrogen Hub in Egypt

BP has signed a Memorandum of Understanding (MoU) with the Egyptian Government under which the multinational energy giant will explore the potential for establishing a green hydrogen production plant in the country.

Photo

Saudi’s Dussur Buys into Italmatch Chemicals

Dussur, the Saudi Arabian Industrial Investments Company, has agreed to buy a stake in Italian specialty additives manufacturer Italmatch Chemicals from private equity group Bain Capital. The Riyadh-based group will also invest €100 million in Italmatch as a capital increase.

Photo

CEFIC Chemicals Trends Report November 2022

Following months of deteriorations, the latest global manufacturing flash PMI (Purchasing Managers' Index) reading has, for the first time since mid-2020, crossed the threshold of 50. This signals a contraction in manufacturing, CEFIC says in their Chemicals Trends Report (CTR) for November 2022.

Photo

Air Products and AES Plan US Mega-Scale Hydrogen Plant

Industrial gases company Air Products and utility group AES have announced plans to invest $4 billion in a mega-scale hydrogen plant, powered by wind and solar energy. The companies said the facility, which will be capable of producing more than 200 t/d, will be the largest green hydrogen plant in the US when it starts up in 2027.

Photo

Plastics Industry Slams new US Legislative Proposal

US chemicals and plastics producers have expectedly slammed a new legislative initiative called Protecting Communities from Plastics Act (PCPA) introduced by Democratic Party senators and representatives in both houses of Congress at the beginning of December.

Photo

Germany’s Merck Buys Erbi Biosystems

Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The company is based in the US state of Massachusetts.

Photo

Röhm to Acquire SABIC’s PC Sheet and Film Business

PMMA specialist Röhm plans to acquire SABIC’s polycarbonate-based Functional Forms business in a deal due to close in H1 2024. The company said the buy is key to its strategy to advance its transparent semi-finished products business into a leading multi-polymer global player.

Photo

CropEnergies Proceeds with German Ethyl Acetate Plant

Germany’s CropEnergies has given the go-ahead for its proposed 50,000 t/y renewable ethyl acetate plant to be built at the Zeitz Chemical and Industrial Park in Elseraue. Total investment will be between €120-130 million, with startup scheduled by summer 2025.

Photo

Nouryon Buys Singapore Alkoxylation Plant

Nouryon has bought an alkoxylation plant in Singapore. The company said the plant on Jurong Island will enhance its ability to serve growing regional demand in key end-markets, such as agriculture and food, home and personal care, natural resources, and paints and coatings.

Photo

Pfizer Files Rebuttal of Moderna’s Patent Claim

Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine Comirnaty, the New York US drugs giant said in a court filing that Comirnaty was based on independent research and wasn’t a Moderna copy.

Photo

AstraZeneca Sells US Site to National Resilience

Two weeks after annnouncing that it would no longer seek to market its Covid-19 vaccine in the US, Anglo-Swedish drugmaker AstraZeneca has unveiled plans to sell its production site at West Chester, Ohio, to privately-held biomanufacturing company National Resilience.

12381 more News

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing